Lisa Ricciardi

Executive

Chairman & CEO

Insider activity · 24 months2 buys0 salesCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 1 buy · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 1 buy · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (8 ops.)

€305k

▼ Sales (0 ops.)

—

Latest filing published 20 Apr 2026 for Cognition Therapeutics INC, €8,566.

Filing timeline

BuySale

Lisa Ricciardi

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

40%

T+90 mean return

-16.6%

Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Lisa Ricciardi: trading record in brief

Lisa Ricciardi, listed as chief executive, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Cognition Therapeutics Inc, Sepracor Inc /DE/ and Chimerix Inc. Over a trading history stretching from 20 May 2008 to 16 April 2026, the count stands at 28 filings.

Every open-market trade on record is a purchase: 8 purchases worth €305k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 18 share grants. Since January 2026: 1 purchase and no sales on the market.

Half of the purchases are above €22k and half below. 4 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

On 20 April 2026 came the latest disclosure, an open-market purchase for €8,566 in Cognition Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.